A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1997
12/18/1997	WO1997047294A1 Antibacterial agents and cosmetics and clothes containing the same
12/18/1997	WO1997047293A1 Use of preparations containing opiate antagonists and agonists for the prevention and therapeutic treatment of migraines
12/18/1997	WO1997047292A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds
12/18/1997	WO1997047286A1 Medicinal aerosol formulations of formoterol
12/18/1997	WO1997047283A1 Combination of acid protease enzymes and acidic buffers and uses thereof
12/18/1997	WO1997047278A1 Composition having tanning and sun-screening activity, and cosmetic uses thereof
12/18/1997	WO1997047276A1 The use of l-lysine in the treatment of hair loss
12/18/1997	WO1997047271A2 Cellular vaccines and immunotherapeutics and methods for their preparation
12/18/1997	WO1997047270A2 Novel anti-viral compounds
12/18/1997	WO1997047209A1 Lipid metabolism ameliorants
12/18/1997	WO1997047194A1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
12/18/1997	WO1997047171A1 Skin wash composition
12/18/1997	WO1997041845A3 Use of fatty alcohol ethers for the inhibition of neurodegenerative diseases
12/18/1997	WO1997035982A3 Monocyte chemotactic protein-5 materials and methods
12/18/1997	WO1997035015A3 Tyrosine-phosphatase-related protein
12/18/1997	WO1997034627A3 Protection of hemopoietic cells during chemotherapy or radiotherapy
12/18/1997	WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
12/18/1997	WO1997029183A3 Methods and compositions for transforming dendritic cells and activating t cells
12/18/1997	WO1997025052A3 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons
12/18/1997	CA2258560A1 Novel anti-viral compounds
12/18/1997	CA2258553A1 Cellular injury response element and uses thereof
12/18/1997	CA2258082A1 Cellular vaccines and immunotherapeutics and methods for their preparation
12/18/1997	CA2257990A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds
12/18/1997	CA2257913A1 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine
12/18/1997	CA2257902A1 Novel devices for transdermal administering of trimegestone
12/18/1997	CA2257882A1 Antirheumatic agent
12/18/1997	CA2257693A1 Therapeutic treatment for cardiovascular diseases
12/18/1997	CA2257614A1 Novel heparin binding peptides
12/18/1997	CA2257422A1 Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents
12/18/1997	CA2257275A1 New substituded 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them
12/18/1997	CA2257137A1 Synthetic hepatitis c genes
12/18/1997	CA2256649A1 Inhibition of serotonin reuptake
12/18/1997	CA2251575A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
12/18/1997	CA2229210A1 Antibacterial agents and cosmetics and clothes containing the same
12/18/1997	CA2208581A1 Substituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions
12/18/1997	CA2207886A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
12/17/1997	EP0812845A1 Process for preparing sildenafil
12/17/1997	EP0812844A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
12/17/1997	EP0812842A2 Process for the preparation of 5-(alkoxymethyl)-2,3-pyridine-dicarboximide compounds
12/17/1997	EP0812841A1 Crystal of N-((quinolin-2-yl)-phenyl)sulfonamides and process for producing the same
12/17/1997	EP0812838A1 Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
12/17/1997	EP0812835A1 Optically active thiazolidinone derivatives
12/17/1997	EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists
12/17/1997	EP0812828A1 Process for the preparation of (5,6-dicarboxy-3-pyridyl) methyl ammonium halides
12/17/1997	EP0812826A1 1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake
12/17/1997	EP0812594A1 Compounds that interfere with DNA replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
12/17/1997	EP0812593A1 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
12/17/1997	EP0812592A1 An agent for the prevention or treatment of cataracts
12/17/1997	EP0812591A1 Injectable compositions containing Nimesulide
12/17/1997	EP0812590A2 Use of R-alpha lipoic acid for cytoprotection
12/17/1997	EP0812589A1 Combined antipyretic analgesic drug
12/17/1997	EP0812588A1 External preparation
12/17/1997	EP0812587A1 Transdermal compositions containing Nimesulide
12/17/1997	EP0812355A2 Agent for treating tumours and other hyperplasia
12/17/1997	EP0812323A1 Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
12/17/1997	EP0812321A1 Prokinetic oxadiazoles
12/17/1997	EP0812319A1 2-arylbenzazole compounds
12/17/1997	EP0812318A1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
12/17/1997	EP0812316A1 Novel derivatives of ethyl-1 dihydro-1,2 oxo-2 methylamino-3 quinoxaline, utilization as drugs, and pharmaceutical compositions containing them
12/17/1997	EP0812315A1 Pyrazolotetracyclines
12/17/1997	EP0812212A1 Compositions for the delivery of antigens
12/17/1997	EP0812209A1 Cochleate phospholipids in drug delivery
12/17/1997	EP0812203A1 Inhibitors of geranylgeranyl-protein transferase
12/17/1997	EP0812199A1 Sphingosine, methylsphingosine and apoptosis
12/17/1997	EP0812198A1 Storage-stable prostaglandin compositions
12/17/1997	EP0812197A2 Use of moxonidine for the treatment of atherosclerosis
12/17/1997	EP0812196A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/17/1997	EP0812195A1 Pharmaceutical composition for piperidinoalkanol compounds
12/17/1997	EP0812194A1 Method for treating atopic dermatitis and contact dermatitis
12/17/1997	EP0812193A1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent
12/17/1997	EP0812192A1 Benzothiopyranoindazoles antitumor agents
12/17/1997	EP0812190A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
12/17/1997	EP0812189A2 Use of fluorocarbon liquids for accelerating lung and other tissue growth
12/17/1997	EP0812188A2 Methods and pharmaceutical compositions employing desmethylselegiline
12/17/1997	EP0812185A2 Use of angiogenesis suppressors for inhibiting hair growth
12/17/1997	EP0812184A1 Nitric oxide synthase inhibitors
12/17/1997	EP0719277B1 Androstenones
12/17/1997	EP0698025B1 Ampa antagonists and a method of treatment therewith
12/17/1997	EP0656902B1 Peptide lung surfactants and therapeutic combinations
12/17/1997	EP0652750B1 Use of alpha,omega-dicarboxylic acids as fibrinogen reducers
12/17/1997	EP0651743B1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors
12/17/1997	EP0649430B1 Derivatives of 16-membered ring antibiotic macrolides
12/17/1997	EP0644762B1 Pyrazolopyridine compounds for the treatment of anemia
12/17/1997	EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
12/17/1997	EP0593601B1 Novel compositions based on taxane class derivatives
12/17/1997	EP0591311B1 Controlled release systems and low dose androgens
12/17/1997	EP0559845B1 Use of compounds in preventing endotoxin shock
12/17/1997	EP0549729B1 Antiviral compounds and antihypertensive compounds
12/17/1997	EP0533818B1 Process for activating reproduction of seasonal breeding animals by administering l-dihydroxyphenylalanine (l-dopa)
12/17/1997	EP0533804B1 Sigma binding site agents
12/17/1997	EP0526543B1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
12/17/1997	EP0515550B1 Heparin neutralization with platelet factor 4
12/17/1997	EP0458901B1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
12/17/1997	EP0275249B2 Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments
12/17/1997	EP0202276B2 Composition for the treatment of psoriasis
12/17/1997	CN1168142A Novel peptides, their production and use
12/17/1997	CN1168140A Hydroxymethyl imidazodiazepines and their esters
12/17/1997	CN1168139A Camptothecin derivs. and their mfg. method
12/17/1997	CN1168138A Aryl and heteroaryl purine compounds
12/17/1997	CN1168137A Pyridazinones as endothelin-receptor antagonists

1 ... 6711 6712 6713 6714 6715 6716 6717 6718 6719 6720 6721 6722 6723 6724 6725 6726 6727 6728 6729 6730 6731 ... 7860